| Literature DB >> 35141263 |
Li-Xia Dai1, Xiaolou Miao1, Xiao-Rong Yang1, Li-Ping Zuo2, Zhi-Hui Lan2, Bing Li1, Xiao-Fei Shang1,3, Feng-Yuan Yan2, Xiao Guo3, Yu Wang1, Ji-Yu Zhang1.
Abstract
Rhubarb plants (Rheum officinale and R. tanguticum) have edible stalks. In this work, we aimed to compare the nutritional properties, chemical compositions, and bioactivities of R. officinale (SRO) and R. tanguticum (SRT) stalks and to analyze the composition-function relationship. Results showed that the two stalks were good sources of fiber, as well as minerals. They contained abundant essential amino acids and essential fatty acids to regulate the immunity and prevent some chronic diseases; the contents of polyunsaturated fatty acids were 2,244.32 mg/100 g and 2,844.69 mg/100 g, respectively. The antioxidant activity were also proved. Metabolomics showed that SRO and SRT contained abundant phenolic acids. Due to the higher concentrations of flavones, SRT has better antiinflammatory activities than SRO by inhibiting NF-κB signaling pathway. Rhubarb stalks exhibited good safety in acute toxicity and cytotoxicity tests. This work indicated that the two stalks have nutritional value, safety, and bioactivities, and could be used as sources of nutritional ingredients for regulating the immunity of body in food industry.Entities:
Keywords: Rheum officinale; Rheum tanguticum; antioxidant activity; chemical compositions; nutritional value
Year: 2022 PMID: 35141263 PMCID: PMC8819138 DOI: 10.3389/fnut.2021.770264
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
The nutritional values of R. officinale and R. tanguticum stalks.
|
|
|
|
| ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Lipids | 0.51 ± 0.03a | 0.40 ± 0.03b | Calcium | 3,280.1 ± 15.29a | 4,280.3 ± 39.56b | Gly | 281.23 ± 14.25a | 480.32 ± 24.58b | C10 | 11.30 ± 2.11 | – |
| Proteins | 6.06 ± 1.12a | 9.51 ± 0.98b | Sodium | 47.60 ± 1.23a | 67.45 ± 3.25b | Ala | 273.21 ± 16.57a | 490.42 ± 29.10b | C11 | – | – |
| Moisture | 7.31 ± 0.87a | 5.90 ± 1.01b | Potassium | 661.26 ± 10.11a | 1,094.27 ± 9.56b | Val* | 340.07 ± 21.45a | 601.35 ± 19.89b | C12 | 77.76 ± 19.21a | 18.73 ± 3.25b |
| Fiber | 11.71 ± 1.66a | 13.17 ± 2.05a | Iron | 1.75 ± 0.09a | 2.96 ± 0.25b | Leu* | 401.33 ± 12.16a | 800.83 ± 65.34b | C13 | 13.01 ± 1.12a | 76.74 ± 13.12b |
| Ash | 15.07 ± 2.17a | 17.53 ± 2.12a | Phosphorus | 230.05 ± 34.89a | 240.67 ± 21.89a | Ile* | 200.89 ± 12.14a | 422.51 ± 9.54b | C14 | 19.32 ± 1.18a | 19.26 ± 2.35a |
| Carbohydrates | 66.65 ± 5.23a | 59.39 ± 6.36a | Copper | 0.17 ± 0.02a | 0.16 ± 0.08a | Pro | 790.09 ± 17.56a | 1,050.12 ± 54.23b | C14:1 | 9.27 ± 1.12 | – |
| Manganese | 10.32 ± 2.14a | 5.39 ± 1.17b | Ser | 311.26 ± 12.43a | 503.25 ± 8.99b | C15 | 24.43 ± 3.21a | 20.08 ± 4.51a | |||
| Magnesium | 43.60 ± 2.68a | 61.62 ± 3.63b | Cys | 70.01 ± 9.87a | 210.90 ± 10.76b | C15:1 | 10.61 ± 1.23a | 9.41 ± 2.12a | |||
| Selenium | – | – | Met* | – | 30.00 ± 3.00 | C16 | 860.16 ± 56.81a | 958.06 ± 72.31a | |||
| Zinc | 0.84 ± 0.12a | 0.84 ± 0.09a | Thr* | 233.21 ± 23.19a | 450.09 ± 16.98b | C16:1 | 20.77 ± 3.12a | 18.90 ± 1.89a | |||
| Total | 4,275.5 ± 56.23a | 5,747.8 ± 32.15b | Phe* | 180.09 ± 8.67a | 121.11 ± 3.21b | C17 | 16.56 ± 3.45a | 11.25 ± 5.21a | |||
| Tyr | 460.98 ± 24.89a | 592.65 ± 35.89b | C18 | 83.63 ± 25.41a | 72.30 ± 31.23b | ||||||
| Asp | 498.78 ± 15.87a | 1,080.02 ± 87.23b | C18:1 | 680.28 ± 11.23a | 509.28 ± 7.89b | ||||||
| Glu | 1,213.16 ± 36.12a | 1,630.08 ± 76.28b | C18:2 | 1,617.16 ± 23.45a | 1,936.4 ± 41.21b | ||||||
| Lys* | 330.09 ± 19.21a | 581.31 ± 24.34b | C18:3 | 524.63 ± 67.23a | 592.97 ± 52.31a | ||||||
| Arg | 290.00 ± 10.21a | 563.21 ± 18.91b | C20 | – | 13.29 ± 2.45 | ||||||
| His* | 150.02 ± 7.89a | 221.21 ± 14.42b | C20:1 | 15.12 ± 1.32a | 14.64 ± 3.41a | ||||||
| Total | 6,024.42 ± 93.25a | 9,829.38 ± 72.13b | C20:2 | – | 123.07 ± 34.23 | ||||||
| E-total | 1,835.70 ± 91.23a | 3,228.41 ± 64.21b | C20:3 | 46.85 ± 45.71a | 57.46 ± 34.51b | ||||||
| C21 | 52.38 ± 18.89a | 57.01 ± 23.12a | |||||||||
| C22:6 | 55.68 ± 9.21a | 134.79 ± 18.21b | |||||||||
| C23 | 28.10 ± 3.12 | – | |||||||||
| C24 | 82.20 ± 34.12a | 109.93 ± 29.11a | |||||||||
| Total | 4,249.22 ± 62.23a | 4,753.57 ± 82.12a | |||||||||
| SFA | 1,268.85 ± 30.11a | 1,356.65 ± 22.31a | |||||||||
| MUFA | 736.05 ± 28.35a | 552.23 ± 36.78a | |||||||||
| PUFA | 2,244.32 ± 40.10a | 2,844.69 ± 24.16b | |||||||||
SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; E-total, The total contents of eight essential proteins and one protein (His) for children. Different letters denote of data significant difference at p <0.05 between the two group and those followed by same letters denote no significant difference.
Figure 1The chromatographic pictures of UHPLC-QQQ-MS-based metabolomics. [(A) negative ion for SRO; (B) positive ion for SRO; (C) negative ion for SRT; (D) positive ion for SRT].
Figure 2The number of compounds (A), metabolites (B), and flavones (C) in SRO and SRT, and the metabolite ion intensity of secondary in SRO and SRT (D); the cell viability (E); SC50 values for DPPH radical scavenging activity (F), hydroxyl radical scavenging activity (G), and superoxide radical scavenging activity (H); the SOD activity (I), CAT activity (J), and MDA content (K) in RAW264.7 cells induced by H2O2 [For (F–H), the different letter represents the significant difference, p < 0.05; for (I–K), ###represent the significant difference between control group and model group, p < 0.001; *p < 0.05 represent the significant difference between model group and drug-treated group; **p < 0.01; *** for p < 0.001].
Top ten compounds identified from SRO and SRT.
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|
|
| ||||||
| 1 | Negative | 432.106 | C21H20O10 | [M-H]− | Emodin-6-O-glucoside | Anthracene derivatives |
| 2 | Negative | 192.027 | C6H8O7 | [M-H]− | Citric acid | Organic acids |
| 3 | Positive | 121.089 | C8H11N | [M+H]+ | Phenethylamine | Alkaloids |
| 4 | Negative | 408.142 | C20H24O9 | [M-H]− | Torachrysone-8-O-glucoside | Phenolic acids |
| 5 | Negative | 510.131 | C30H22O8 | [M-H]− | Palmidin A | Anthracene derivatives |
| 6 | Negative | 192.027 | C6H8O7 | [M-H]− | Isocitric Acid | Phenolic acids |
| 7 | Negative | 246.089 | C14H14O4 | [M-H]− | Torachrysone | Phenolic acids |
| 8 | Negative | 154.027 | C7H6O4 | [M-H]− | Gentisic acid | Phenolic acids |
| 9 | Negative | 180.042 | C9H8O4 | [M-H]− | Caffeic acid | Phenolic acids |
| 10 | Positive | 141.09 | C6H11N3O | [M+H]+ | Histidinol | Phenolic acids |
|
| ||||||
| 1 | Negative | 432.106 | C21H20O10 | [M-H]− | Isovitexin | Flavonoids |
| 2 | Negative | 432.106 | C21H20O10 | [M-H]− | Vitexin | Flavonoids |
| 3 | Positive | 313.131 | C18H19NO4 | [M+H]+ | N-Feruloyltyramine | Alkaloids |
| 4 | Negative | 192.027 | C6H8O7 | [M-H]− | Citric Acid | Organic acids |
| 5 | Positive | 187.063 | C11H9NO2 | [M+H]+ | 3-Indoleacrylic acid | Alkaloids |
| 6 | Negative | 432.106 | C21H20O10 | [M-H]− | Emodin-6-O-glucoside | Anthracene derivatives |
| 7 | Negative | 304.058 | C15H12O7 | [M-H]− | Dihydroquercetin | Flavonoids |
| 8 | Negative | 180.042 | C9H8O4 | [M-H]− | Caffeic acid | Phenolic acids |
| 9 | Negative | 192.027 | C6H8O7 | [M-H]− | Isocitric acid | Organic acids |
| 10 | Negative | 154.027 | C7H6O4 | [M-H]− | Protocatechuic acid | Phenolic acids |
Figure 3The NO content (A), IL-1β content (B), TNF-α content (C), and NF-κB content (D) in RAW264.7 cells induced by LPS; the western blot assay for determining the expression of IκB and NF-κB (E); the p-NF-κB/NF-κB ration for SRO (F) and SRT (G); the p-IκB/IκB ration for SRO (H) and SRT (I) (###represent the significant difference between control group and model group, p < 0.001; *p < 0.05 represent the significant difference between model group and drug-treated group; **p < 0.01; ***p < 0.001).
Figure 4The fluorescence for measuring the cellular ROS production (A) and the NF-κB signaling pathway (B) of RAW264.7 cells treated by SRO and SRT.
Figure 5The fluorescence for indicating the cellular MMP of RAW264.7 cells treated by SRO and SRT.